Back to discover
Drug

Hydroxyproline

Research stage
Emerging research

Also known as trans-4-Hydroxy-L-proline, trans-L-Hydroxyproline.

RxNorm1311548ChEMBLCHEMBL352418UNIIRMB44WO89X
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Hydroxyproline
Aliases & brands
trans-4-Hydroxy-L-prolinetrans-L-Hydroxyproline
RxNorm CUI
1311548
ChEMBL ID
CHEMBL352418
UNII
RMB44WO89X

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Journals, researchers & institutions
Top journals
  • Amino acids1
Leading researchers
  • Wu G1
Leading institutions
free-text, unnormalised
  • Texas A&M University1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Creatine

Frequently co-studied with Hydroxyproline in the research literature.

1 shared paper
Taurine

Frequently co-studied with Hydroxyproline in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature